Abstract
Supply shortages and limits on research leave low- and middle-income countries struggling to access Pfizer’s COVID-19 antiviral. [Figure not available: see fulltext.]
Author supplied keywords
Cite
CITATION STYLE
APA
Ledford, H., & Maxmen, A. (2022, April 21). African clinical trial denied access to key COVID drug Paxlovid. Nature. Nature Research. https://doi.org/10.1038/d41586-022-00919-5
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free